Evidence map›Paper›PMID 36002001›Full record

ArticleMolecular cell2022

Mitotic DNA synthesis is caused by transcription-replication conflicts in BRCA2-deficient cells.

Florian J Groelly, Rebecca A Dagg, Michalis Petropoulos, Giacomo G Rossetti, Birbal Prasad, Andreas Panagopoulos, Teressa Paulsen, Angeliki Karamichali, Samuel E Jones, Fena Ochs and 9 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular cell, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 3 countries.

Florian J GroellyGenome Stability and Tumourigenesis Group, Department of Oncology, Oxford Institute for Radiation Oncology, University of Oxford, Oxford OX3 7DQ, UK.
Rebecca A DaggGenome Stability and Tumourigenesis Group, Department of Oncology, Oxford Institute for Radiation Oncology, University of Oxford, Oxford OX3 7DQ, UK.
Michalis PetropoulosDepartment of Molecular Biology, University of Geneva, 1205 Geneva, Switzerland.
Giacomo G RossettiDepartment of Molecular Biology, University of Geneva, 1205 Geneva, Switzerland.
Birbal PrasadGenome Stability and Tumourigenesis Group, Department of Oncology, Oxford Institute for Radiation Oncology, University of Oxford, Oxford OX3 7DQ, UK.
Andreas PanagopoulosDepartment of Molecular Mechanisms of Disease, University of Zurich, 8057 Zurich, Switzerland.
Teressa PaulsenGenome Stability and Tumourigenesis Group, Department of Oncology, Oxford Institute for Radiation Oncology, University of Oxford, Oxford OX3 7DQ, UK.
Angeliki KaramichaliDepartment of Molecular Biology, University of Geneva, 1205 Geneva, Switzerland.
Samuel E JonesDepartment of Oncology, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK.
Fena OchsDepartment of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK.
Vasilis S DionellisDepartment of Molecular Biology, University of Geneva, 1205 Geneva, Switzerland.
Emilia Puig LombardiGenome Stability and Tumourigenesis Group, Department of Oncology, Oxford Institute for Radiation Oncology, University of Oxford, Oxford OX3 7DQ, UK.
Matthieu J MiossecBioinformatics and Statistical Genetics Core, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK.
Helen LockstoneBioinformatics and Statistical Genetics Core, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK.
Gaëlle LegubeLBCMCP, Centre de Biologie Intégrative (CBI), CNRS, Université de Toulouse, UT3, Toulouse 31062, France.
Andrew N BlackfordDepartment of Oncology, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK.
Matthias AltmeyerDepartment of Molecular Mechanisms of Disease, University of Zurich, 8057 Zurich, Switzerland.
Thanos D HalazonetisDepartment of Molecular Biology, University of Geneva, 1205 Geneva, Switzerland. Electronic address: thanos.halazonetis@unige.ch.
Madalena TarsounasGenome Stability and Tumourigenesis Group, Department of Oncology, Oxford Institute for Radiation Oncology, University of Oxford, Oxford OX3 7DQ, UK. Electronic address: madalena.tarsounas@oncology.ox.ac.uk.
University of Geneva · CHUniversity of Oxford · GBCRUK/MRC Oxford Institute for Radiation Oncology · GBJohn Radcliffe Hospital · GBUniversity of Zurich · CHCentre National de la Recherche Scientifique · FR

Funding

Cancer Research UK 20772Cancer Research UK C29215/A20772Cancer Research UK DRCPGM\100001Wellcome Trust 203141/Z/16/Z
6 · The paper itself

Abstract

Aberrant replication causes cells lacking BRCA2 to enter mitosis with under-replicated DNA, which activates a repair mechanism known as mitotic DNA synthesis (MiDAS). Here, we identify genome-wide the sites where MiDAS reactions occur when BRCA2 is abrogated. High-resolution profiling revealed that these sites are different from MiDAS at aphidicolin-induced common fragile sites in that they map to genomic regions replicating in the early S-phase, which are close to early-firing replication origins, are highly transcribed, and display R-loop-forming potential. Both transcription inhibition in early S-phase and RNaseH1 overexpression reduced MiDAS in BRCA2-deficient cells, indicating that transcription-replication conflicts (TRCs) and R-loops are the source of MiDAS. Importantly, the MiDAS sites identified in BRCA2-deficient cells also represent hotspots for genomic rearrangements in BRCA2-mutated breast tumors. Thus, our work provides a mechanism for how tumor-predisposing BRCA2 inactivation links transcription-induced DNA damage with mitotic DNA repair to fuel the genomic instability characteristic of cancer cells.

Indexed as

DNA ReplicationMitosisAphidicolinBRCA2 ProteinChromosome Fragile SitesDNADNA DamageGenomic InstabilityHumansAphidicolinBRCA2 ProteinBRCA2 protein, humanDNABRCA2genome stabilityMiDASmitotic DNA synthesisR-loopstranscription-replication conflictsTRCs

Identifiers

PMID36002001
PMCPMC9631240
OpenAlexW4292756221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.